REVENUES

3 Months Ended

Mar. 31, 2019

Income Statement [Abstract]

REVENUES

NOTE 5 – REVENUES

The following table summarizes the Company’s disaggregation of revenues:

	Three months ended March 31,
(U.S. dollars in thousands)	2019		2018
Pfizer	$	1,356	$	1,980
Brazil	$	2,174	$	2,573
Total revenues from selling goods	$	3,530	$	4,553
Revenues from license and R&D services	$	6,909	$	2,161

The following table sets forth data regarding the Company’s contract liability:

	Three months ended March 31,
(U.S. dollars in thousands)	2019			2018
Contract liabilities at the beginning of the period	$	42,895		$	25,015
Additions during the period		6,422			2,179
Revenue recognized during the period		(6,909	)		(2,161	)
Contract liabilities at the end of the period	$	42,408		$	25,033

The following table represents the Company's unsatisfied performance obligation:

	March 31,
(U.S. dollars in thousands)	2019		2018
Unsatisfied performance obligation	$	64,581	$	91,033